BPC 157: The peptide with big claims and scant evidence STAT The peptide problem: Hype is outrunning the evidence How different peptide therapies may affect your body Prenuvo blog The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law Is BPC 157 Banned? Oral vs. Injectable Forms Explained